The forecasted use of antiinfective medicines in Belgium shows a gradual decline from 23.7 Units (Defined Daily Dosage) per Thousand Persons Per Day in 2024 to 22.8 Units in 2028. The year-on-year variations indicate a steady decrease of approximately 1.3% in 2025, 1.28% in 2026, 0.43% in 2027, and 0.87% in 2028. The Compound Annual Growth Rate (CAGR) over the five-year period from 2024 to 2028 is projected to be -0.96%, indicating a modest but consistent reduction in the use of these medicines.
Future trends to watch for include the impact of public health initiatives aimed at reducing antibiotic resistance, changes in disease prevalence, and shifts in healthcare practices. Additionally, monitoring the introduction of new and more effective antiinfective treatments could further influence usage patterns.
